跳至主要内容
临床试验/NCT01800708
NCT01800708已完成不适用

The Use of Intraocular Triamcinolone in the Perioperative Period of Congenital Cataract Surgery

Fundação Altino Ventura1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2010年1月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
60
试验地点
1
主要终点
Visual axis obscuration

研究概览

简要总结

The aim of the present study is to investigate the outcomes of congenital cataract surgery when injecting intraoperative intracameral triamcinolone versus the postoperative use of oral prednisolone.

This is a prospective, randomized clinical trial. Sixty children will be submitted to congenital cataract surgery younger than 2 years of age. They will be randomly divided in two groups. The study group will receive an intraoperative intracameral triamcinolone acetonide injection. The control group will receive prednisolone syrup postoperatively. The surgical outcomes will be assessed after one year.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
6 Weeks 至 2 Years(Child)
性别
All
接受健康志愿者

入选标准

  • Patients younger than 2 years of age
  • Unilateral or bilateral congenital cataracts compromising the red reflex

排除标准

  • Corneal opacity
  • Subluxated cataract
  • Traumatic cataract
  • Complex microphthalmia
  • Persistant hyperplastic primary vitreous
  • Retinal detachment
  • Patients with intraoperative complications, such as IOL implanted in the sulcus

研究组 & 干预措施

Prednisolone syrup

Active Comparator

The control group will receive prednisolone syrup postoperatively

干预措施: Prednisolone syrup (Drug)

Triamcinolone acetonide

Active Comparator

The study group will receive an intraoperative intracameral injection of triamcinolone acetonide

干预措施: Triamcinolone acetonide (Drug)

结局指标

主要结局

Visual axis obscuration

时间窗: 1 year after surgery

Visual axis obscuration will be evaluated under sedation, with a dilated pupil. All patients will be classified by the principal investigator as having or not a significant visual axis obscuration, based on the red reflex.

Intraocular pressure

时间窗: 1 year after surgery

次要结局

未报告次要终点

研究者

发起方
Fundação Altino Ventura
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验